Devices › Device types
FDA product code LWS · class 3 · Unknown
Implantable cardioverter defibrillator (non-crt): medical device reports filed with FDA
380,959 reports carry this product code, 1992–2026; 30 brands with a page.
- 380,959
- reports with this product code
- 1.5% of all MAUDE reports
- 23,653
- reports, 12 months to August 2026
- 24,744 in the 12 months before
- 37.4%
- classified as malfunction
- 62.3% across all reports
- 2.7%
- classified as death, as reported
- 0.9% across all reports
Product code LWS is FDA's classification for "Implantable cardioverter defibrillator (non-crt)" (unknown panel), a class 3 device. 380,959 medical device reports carry this product code, 1.5% of the MAUDE database, from July 1992 to August 2026.
23,653 reports arrived in the 12 months to August 2026, close to the 24,744 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (59.6%), malfunction (37.4%) and death (2.7%). 30 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Sprint Quattro Secure S MRI SureScan | 36,889 | 6,436 | 1.4% | 41.5% |
| Emblem Mri S-Icd | 21,479 | 3,088 | 0.2% | 29.8% |
| Sprint Quattro Secure | 19,549 | 2 | 5.2% | 31.7% |
| Emblem S-Icd | 17,246 | 2,237 | 0.1% | 23.9% |
| Sprint Fidelis | 16,993 | 340 | 14.1% | 12.3% |
| Sprint Quattro Secure S | 14,395 | 0 | 2.4% | 38.1% |
| Endotak Reliance | 9,853 | 238 | 1.2% | 30.7% |
| Sprint Quattro Secure MRI SureScan | 8,716 | 1,903 | 1.4% | 39.9% |
| Endotak Reliance G | 7,334 | 1,049 | 0.6% | 39.1% |
| Teligen | 6,438 | 47 | 0.6% | 36.7% |
| Durata Sts Optim Active Fixation | 5,732 | 301 | 5.6% | 33.6% |
| Sprint Quattro | 5,578 | 0 | 2.6% | 23.1% |
| Reliance 4-Front | 5,491 | 2,024 | 0.4% | 35.1% |
| Sprint | 5,479 | 161 | 2.4% | 18.3% |
| Vitality 2 | 4,379 | 0 | 1% | 61.4% |
| S-Icd System | 4,327 | 0 | 1.1% | 30.3% |
| Fortify Assura VR ICD, US | 4,218 | 213 | 2.3% | 32.2% |
| Implantable Cardioverter Defibrillator Non-Crt | 3,063 | 197 | 0.5% | 76.9% |
| Visia AF MRI XT VR SureScan | 2,372 | 325 | 1.6% | 23.8% |
| Transvene | 2,225 | 0 | 2% | 7.1% |
| Endotak Reliance Sg | 2,180 | 1,083 | 0.5% | 43.1% |
| Riata Active Fixation | 2,088 | 96 | 1.8% | 46.8% |
| Vitality | 1,901 | 0 | 0.9% | 64.1% |
| Energen | 1,851 | 0 | 0.6% | 41.2% |
| Incepta | 1,764 | 0 | 0.7% | 39% |
| Quadra Assura MP ICD | 1,728 | 507 | 2.1% | 72.1% |
| Virtuoso Vr | 1,516 | 0 | 4.7% | 13.9% |
| Autogen | 1,483 | 212 | 1% | 52.2% |
| Evera Xt Vr | 1,474 | 91 | 4.1% | 33.6% |
| Endotak Dsp | 1,400 | 14 | 1.6% | 59.9% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Boston Scientific | 71,350 | 18.7% |
| Mpri | 67,400 | 17.7% |
| Guidant Crm Clonmel Ireland | 29,666 | 7.8% |
| Cardiac Pacemakers | 26,151 | 6.9% |
| Medtronic Puerto Rico | 24,308 | 6.4% |
| St Jude Medical Crmd | 14,251 | 3.7% |
| Medtronic | 12,522 | 3.3% |
| Medtronic Europe Sarl | 12,356 | 3.2% |
| Cpi - Del Caribe | 11,749 | 3.1% |
| St Jude Medical Crm-Sylmar | 9,912 | 2.6% |
| St Jude Medical Crm-Sunnyvale | 9,580 | 2.5% |
| Medtronic Med Rel | 9,332 | 2.4% |
| St Jude Medical Cardiac Rhythm Management Division | 9,125 | 2.4% |
| Medtronic Puerto Rico Villalba | 8,579 | 2.3% |
| Medtronic Med Rel Medtronic Puerto Rico | 8,109 | 2.1% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Over-sensing | 80,485 | 21.1% |
| High impedance | 59,567 | 15.6% |
| Inappropriate/inadequate shock/stimulation | 48,817 | 12.8% |
| Premature discharge of battery | 30,899 | 8.1% |
| Signal artifact/noise | 30,329 | 8% |
| Fracturea broken bone | 22,183 | 5.8% |
| Impedance problem | 16,747 | 4.4% |
| Device sensing problem | 14,736 | 3.9% |
| Pacing problem | 14,442 | 3.8% |
| High capture threshold | 13,694 | 3.6% |
| Under-sensing | 11,766 | 3.1% |
| Low impedance | 10,788 | 2.8% |
| Failure to capture | 9,967 | 2.6% |
| Low battery | 9,603 | 2.5% |
| Incorrect, inadequate or imprecise result or readings | 8,797 | 2.3% |
| Failure to read input signal | 8,029 | 2.1% |
| Battery problema problem with the battery | 7,767 | 2% |
| Normal | 7,046 | 1.8% |
| Device dislodged or dislocated | 6,885 | 1.8% |
| Premature elective replacement indicator | 6,615 | 1.7% |
Questions about implantable cardioverter defibrillator (non-crt) reports
What is product code LWS?
FDA's classification code for "Implantable cardioverter defibrillator (non-crt)", class 3, reviewed by the unknown panel. Every device report carries the product code of the device involved.
How many reports carry this code?
380,959 reports through August 2026, 23,653 of them in the latest 12 months.
Which brands appear most often?
Sprint Quattro Secure S MRI SureScan (36,889), Emblem Mri S-Icd (21,479), Sprint Quattro Secure (19,549), Emblem S-Icd (17,246) and Sprint Fidelis (16,993). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.